HIV Testing in a High‐Incidence Population: Is Antibody Testing Alone Good Enough?
Clinical Infectious Diseases2009Vol. 49(3), pp. 444–453
Citations Over TimeTop 10% of 2009 papers
Joanne D. Stekler, Paul D. Swenson, Robert W. Coombs, Joan Dragavon, Katherine K. Thomas, Catherine A. Brennan, Sushil G. Devare, Robert Wood, Matthew R. Golden
Abstract
OraQuick may be less sensitive than enzyme immunoassays during early HIV infection. NAAT should be integrated into HIV testing programs that serve populations that undergo frequent testing and that have high rates of HIV acquisition, particularly if rapid HIV antibody testing is employed. Antigen-antibody combination assays may be a reasonably sensitive alternative to HIV NAAT.
Related Papers
- Characteristics of Human Immunodeficiency Virus Type 1 Reactive Blood Donors Following Nucleic Acid Amplification Test Screening(2007)
- Characteristics and Follow-up Results of the Window Period Blood Donors for Hepatitis C Virus(2007)
- → Persistent Lack of Detectable HIV-1 Antibody in a Person With HIV Infection—Utah, 1995(1996)3 cited
- Application of nucleic acid detection techniques in blood screening(2015)